Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.93B | 6.16B | 6.40B | 6.77B | 5.69B | Gross Profit |
2.01B | 2.11B | 2.21B | 2.35B | 1.73B | EBIT |
538.64M | 677.86M | 846.55M | 907.95M | 420.40M | EBITDA |
693.17M | 820.14M | 971.51M | 1.00B | 534.95M | Net Income Common Stockholders |
418.45M | 519.19M | 628.00M | 671.38M | 308.76M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
288.93M | 347.92M | 337.14M | 486.00M | 377.60M | Total Assets |
4.90B | 4.68B | 4.60B | 4.58B | 4.38B | Total Debt |
1.30B | 1.70B | 1.77B | 1.85B | 2.02B | Net Debt |
1.01B | 1.35B | 1.43B | 1.36B | 1.64B | Total Liabilities |
2.90B | 2.72B | 2.97B | 3.12B | 3.27B | Stockholders Equity |
2.00B | 1.95B | 1.63B | 1.47B | 1.11B |
Cash Flow | Free Cash Flow | |||
328.49M | 327.49M | 443.20M | 597.25M | 970.33M | Operating Cash Flow |
528.08M | 535.78M | 552.00M | 673.26M | 1.01B | Investing Cash Flow |
-186.12M | -206.14M | -108.81M | -76.02M | -33.14M | Financing Cash Flow |
-400.95M | -318.87M | -592.05M | -488.85M | -750.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $14.60B | 13.01 | 40.08% | 2.47% | 3.53% | 13.86% | |
75 Outperform | $29.65B | 27.33 | 49.83% | 1.70% | 2.25% | 1.00% | |
73 Outperform | $699.55B | 36.28 | 22.23% | 1.03% | 5.07% | 25.86% | |
71 Outperform | $406.63B | 53.50 | 32.89% | 0.51% | 6.13% | 12.14% | |
69 Neutral | $2.63B | 6.84 | 21.14% | 1.22% | -3.67% | -14.66% | |
61 Neutral | $13.15B | 14.54 | 31.63% | 6.06% | -4.43% | -24.58% | |
59 Neutral | $11.22B | 10.13 | -1.22% | 3.96% | 1.32% | -18.57% |